ALPMF
Price
$11.10
Change
+$0.40 (+3.74%)
Updated
Aug 8 closing price
Capitalization
20.33B
ALPMY
Price
$11.29
Change
+$0.11 (+0.98%)
Updated
Aug 15 closing price
Capitalization
20.33B
73 days until earnings call
Interact to see
Advertisement

ALPMF vs ALPMY

Header iconALPMF vs ALPMY Comparison
Open Charts ALPMF vs ALPMYBanner chart's image
Astellas Pharma
Price$11.10
Change+$0.40 (+3.74%)
Volume$1.07K
Capitalization20.33B
Astellas Pharma
Price$11.29
Change+$0.11 (+0.98%)
Volume$50.53K
Capitalization20.33B
ALPMF vs ALPMY Comparison Chart in %
Loading...
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMF vs. ALPMY commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMF is a Buy and ALPMY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (ALPMF: $11.10 vs. ALPMY: $11.29)
Brand notoriety: ALPMF and ALPMY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMF: 33% vs. ALPMY: 29%
Market capitalization -- ALPMF: $20.33B vs. ALPMY: $20.33B
ALPMF [@Pharmaceuticals: Major] is valued at $20.33B. ALPMY’s [@Pharmaceuticals: Major] market capitalization is $20.33B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $628.62B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMF’s FA Score shows that 1 FA rating(s) are green whileALPMY’s FA Score has 1 green FA rating(s).

  • ALPMF’s FA Score: 1 green, 4 red.
  • ALPMY’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALPMF and ALPMY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMF’s TA Score shows that 5 TA indicator(s) are bullish while ALPMY’s TA Score has 7 bullish TA indicator(s).

  • ALPMF’s TA Score: 5 bullish, 4 bearish.
  • ALPMY’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, ALPMY is a better buy in the short-term than ALPMF.

Price Growth

ALPMF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while ALPMY (@Pharmaceuticals: Major) price change was +2.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.35%. For the same industry, the average monthly price growth was +5.72%, and the average quarterly price growth was +12.95%.

Reported Earning Dates

ALPMY is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.35% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALPMF($20.3B) and ALPMY($20.3B) have the same market capitalization . ALPMY (58.83) and ALPMF (57.84) have similar P/E ratio . ALPMY YTD gains are higher at: 16.874 vs. ALPMF (12.576). ALPMF (270B) and ALPMY (270B) have comparable annual earnings (EBITDA) . ALPMF (329B) and ALPMY (329B) have equal amount of cash in the bank . ALPMF (927B) and ALPMY (927B) have identical debt. ALPMF (1.77T) and ALPMY (1.77T) have equivalent revenues.
ALPMFALPMYALPMF / ALPMY
Capitalization20.3B20.3B100%
EBITDA270B270B100%
Gain YTD12.57616.87475%
P/E Ratio57.8458.8398%
Revenue1.77T1.77T100%
Total Cash329B329B100%
Total Debt927B927B100%
FUNDAMENTALS RATINGS
ALPMF vs ALPMY: Fundamental Ratings
ALPMF
ALPMY
OUTLOOK RATING
1..100
3220
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
6
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4544
P/E GROWTH RATING
1..100
9696
SEASONALITY SCORE
1..100
5015

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMY's Valuation (6) in the null industry is in the same range as ALPMF (8). This means that ALPMY’s stock grew similarly to ALPMF’s over the last 12 months.

ALPMY's Profit vs Risk Rating (100) in the null industry is in the same range as ALPMF (100). This means that ALPMY’s stock grew similarly to ALPMF’s over the last 12 months.

ALPMY's SMR Rating (100) in the null industry is in the same range as ALPMF (100). This means that ALPMY’s stock grew similarly to ALPMF’s over the last 12 months.

ALPMY's Price Growth Rating (44) in the null industry is in the same range as ALPMF (45). This means that ALPMY’s stock grew similarly to ALPMF’s over the last 12 months.

ALPMY's P/E Growth Rating (96) in the null industry is in the same range as ALPMF (96). This means that ALPMY’s stock grew similarly to ALPMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMFALPMY
RSI
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
61%
Momentum
ODDS (%)
Bullish Trend 3 days ago
52%
Bullish Trend 3 days ago
65%
MACD
ODDS (%)
Bullish Trend 3 days ago
47%
Bullish Trend 5 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 3 days ago
60%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
63%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
58%
Aroon
ODDS (%)
Bearish Trend 3 days ago
55%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GBR1.000.14
+16.52%
New Concept Energy
ARQQ32.950.49
+1.51%
Arqit Quantum Inc
PAX13.760.13
+0.95%
Patria Investments Limited
YPF32.970.28
+0.86%
YPF Sociedad Anonima
EPIX1.930.01
+0.52%
ESSA Pharma

ALPMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMF has been loosely correlated with ALPMY. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMF jumps, then ALPMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMF
1D Price
Change %
ALPMF100%
N/A
ALPMY - ALPMF
40%
Loosely correlated
+0.98%
AZNCF - ALPMF
7%
Poorly correlated
-0.16%
GRFS - ALPMF
4%
Poorly correlated
-0.19%
JNJ - ALPMF
2%
Poorly correlated
+1.10%
BAYRY - ALPMF
-1%
Poorly correlated
+2.33%
More

ALPMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMY has been loosely correlated with ALPMF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMY jumps, then ALPMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMY
1D Price
Change %
ALPMY100%
+0.98%
ALPMF - ALPMY
37%
Loosely correlated
N/A
OPHLY - ALPMY
32%
Poorly correlated
-0.52%
OTSKY - ALPMY
21%
Poorly correlated
+0.16%
BAYRY - ALPMY
13%
Poorly correlated
+2.33%
ABBV - ALPMY
12%
Poorly correlated
+0.98%
More